Yanfei Zhang

Prof. Dr. Yanfei Zhang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2016 in Plant Cell Reports
Verified
Journal Article
Closed access
PDF file
XWXiaoyu Wang
Xiaoyu Wang
XSXiaohui Shan
Xiaohui Shan
CXChunmei Xue
Chunmei Xue
YWYing Wu
Ying Wu
SSShengzhong Su
Shengzhong Su
YYYaping Yuan
Yaping Yuan

20 June 2024 in Biotechnology Journal
Verified
Journal Article
Closed access
QCQian Chen
Qian Chen
YCYunhong Chen
Yunhong Chen
ZHZeming Hou
Zeming Hou
YMYuyue Ma
Yuyue Ma
JHJianfeng Huang
Jianfeng Huang
GZGuoping Zhao
Guoping Zhao

11 June 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MLMeizi Liu
Meizi Liu
ZLZuhui Li
Zuhui Li
JHJianfeng Huang
Jianfeng Huang
JYJunjun Yan
Junjun Yan
GZGuoping Zhao
Guoping Zhao
YZYanfei Zhang
Yanfei Zhang
Optogenetics’ advancement has made light induction attractive for controlling biological processes due to its advantages of fine-tunability, reversibility, and low toxicity. The lactose operon induction system, commonly used in Escherichia coli, relies on the binding of lactose or isopropyl β-d-1-thiogalactopyranoside (IPTG) to the lactose repressor protein LacI, playing a pivotal role in controlling the lactose operon. Here, we harnessed the light-responsive light-oxygen-voltage 2 (LOV2) domain from Avena sativa phototropin 1 as a tool for light control and engineered LacI into two light-responsive variants, OptoLacIL and OptoLacID. These variants exhibit direct responsiveness to light and darkness, respectively, eliminating the need for IPTG. Building upon OptoLacI, we constructed two light-controlled E. coli gene expression systems, OptoE.coliLight system and OptoE.coliDark system. These systems enable bifunctional gene expression regulation in E. coli through light manipulation and show superior controllability compared to IPTG-induced systems. We applied the OptoE.coliDark system to protein production and metabolic flux control. Protein production levels are comparable to those induced by IPTG. Notably, the titers of dark-induced production of 1,3-propanediol (1,3-PDO) and ergothioneine exceeded 110% and 60% of those induced by IPTG, respectively. The development of OptoLacI will contribute to the advancement of the field of optogenetic protein engineering, holding substantial potential applications across various fields.

25 October 2025 in Trends in Biotechnology
Verified
Journal Article
Closed access
JYJunjun Yan
Junjun Yan
YCYunhong Chen
Yunhong Chen
YMYuyue Ma
Yuyue Ma
XYXue Yang
Xue Yang
YYYonghong Yao
Yonghong Yao
YZYanfei Zhang
Yanfei Zhang

17 May 2023 in Polymers
Verified
Journal Article
Open access
PDF file
HDhuaming dong
huaming dong
XYXue Yang
Xue Yang
JSJingjing Shi
Jingjing Shi
CXChunqiao Xiao
Chunqiao Xiao
YZYanfei Zhang
Yanfei Zhang
The extensive utilization of traditional petroleum-based plastics has resulted in significant damage to the natural environment and ecological systems, highlighting the urgent need for sustainable alternatives. Polyhydroxyalkanoates (PHAs) have emerged as promising bioplastics that can compete with petroleum-based plastics. However, their production technology currently faces several challenges, primarily focused on high costs. Cell-free biotechnologies have shown significant potential for PHA production; however, despite recent progress, several challenges still need to be overcome. In this review, we focus on the status of cell-free PHA synthesis and compare it with microbial cell-based PHA synthesis in terms of advantages and drawbacks. Finally, we present prospects for the development of cell-free PHA synthesis.

16 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
XWXinlei Wei
Xinlei Wei
XYXue Yang
Xue Yang
CHCongcong Hu
Congcong Hu
QLQiangzi Li
Qiangzi Li
QLQianqian Liu
Qianqian Liu
CYChun You
Chun You
In vitro biotransformation (ivBT) facilitated by in vitro synthetic enzymatic biosystems (ivSEBs) has emerged as a highly promising biosynthetic platform. Several ivSEBs have been constructed to produce poly-3-hydroxybutyrate (PHB) via acetyl-coenzyme A (acetyl-CoA). However, some systems are hindered by their reliance on costly ATP, limiting their practicality. This study presents the design of an ATP-free ivSEB for one-pot PHB biosynthesis via acetyl-CoA utilizing starch-derived maltodextrin as the sole substrate. Stoichiometric analysis indicates this ivSEB can self-maintain NADP+/NADPH balance and achieve a theoretical molar yield of 133.3%. Leveraging simple one-pot reactions, our ivSEBs achieved a near-theoretical molar yield of 125.5%, the highest PHB titer (208.3 mM, approximately 17.9 g/L) and the fastest PHB production rate (9.4 mM/h, approximately 0.8 g/L/h) among all the reported ivSEBs to date, and demonstrated easy scalability. This study unveils the promising potential of ivBT for the industrial-scale production of PHB and other acetyl-CoA-derived chemicals from starch.